DCI Indonesia Tbk vs Tempo Scan Pacific Tbk. — how do they compare? DCI Indonesia Tbk trades at Rp198,675 (market cap 473.71T, 1K 24h volume), while Tempo Scan Pacific Tbk. trades at Rp2,520 (market cap 11.18T, 613K 24h volume). The key difference: DCI Indonesia Tbk is far larger — about 42.4× Tempo Scan Pacific Tbk.'s market cap, and Tempo Scan Pacific Tbk. is more actively traded (613K versus 1K). Which is the better fit depends on your goals.
| DCII | TSPC | |
|---|---|---|
Market Cap | 473.71T | 11.18T |
Volume | 1K | 613K |
Lot | 10 | 6.13K |
Turnover | 194.12M | 1.54B |
Average Price | 194,120 | 2,511.52 |
Value | 194.12M | 1.54B |
Indicative Equilibrium Price | 199,000 | 2,520 |
Indicative Equilibrium Volume | 1 | 17 |
Trailing returns across standard periods
Latest headlines on both assets
PT DCI Indonesia Tbk (the Company) was established in Indonesia based on Notarial Deed No. 143 of Buntario Tigris, S.H., S.E., M.H., on July 18, 2011. The Company started its commercial operations in 2013. The Company parent entity and ultimate controlling party is DCI International Holding Pte. Ltd., Singapore.
Read more on DCII →PT. Tempo Scan Pacific Tbk (the Company) was established in the Republic of Indonesia dated 20 May 1970, under its original name PT Scanchemie within the framework of the Domestic Capital Investment Law No. 6 year 1968, as amended by Law No. 12 year 1970, based on Notarial Deed No. 37 of Ridwan Suselo, S.H. The company is famous for such pharmaceutical products as Bodrex, Hemaviton and Neo-Rheumacyl.
Read more on TSPC →